BNTX Stock Analysis: Buy, Sell, or Hold?

BNTX - BioNTech SE American Depositary Share

Biological Products, (No Diagnostic Substances)
$90.62
0.43 (0.48%) ▲
5d: -0.2%
30d: -0.34%
90d: +2.5%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026

Get Alerted When BNTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: BNTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: BNTX is currently trading at $90.62, which is considered fair relative to its 30-day fair value range of $87.82 to $92.51.

Technical Outlook: Technically, BNTX is in a downtrend. The price is approaching resistance at $93.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: BNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $121.89 (+34.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $87.82 - $92.51
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 34.5% below Wall St target ($121.89)

Trading Range Analysis

30-Day Trading Range $87.82 - $92.51
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $84.96
Resistance Level $93.25
Current Trend Downtrend
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -20.48
Wall Street Target $121.89 (+34.5%)
Revenue Growth (YoY) -35.4%
Earnings Growth (YoY) -43.2%
Profit Margin -44.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 6:20 AM ET
Data refreshes hourly during market hours. Next update: 7:20 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Sierk Poetting SELL 50000 shares 2026-04-22

Unlock Insider Activity

See real-time buying/selling by company executives for BNTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 67 BUY
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 61 BUY
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 65 BUY
MNMD
Mind Medicine Inc
STRONG BUY
11 analysts
$29 62 BUY
ALLO
Allogene Therapeutics Inc
STRONG BUY
14 analysts
$8 60 HOLD

More Analysis for BNTX

BNTX Technical Chart BNTX Price Prediction BNTX Earnings Date BNTX Investment Advisor BNTX Fair Price Analyzer BNTX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals